Hepatoprotective Effects of Idebenone Against Paracetamol-Induced Liver Injury: Association with Nrf2/HO-1 and NF-κB Signaling Pathways

Paracetamol overdose is a common cause of acute liver injury and is closely associated with oxidative stress and inflammation. Idebenone is a coenzyme Q10 analogue with antioxidant and mitochondrial protective properties. This study aimed to investigate the protective effects of idebenone against paracetamol-induced liver injury in rats. Forty-eight male Wistar rats were divided into six groups: healthy, healthy + idebenone 100 mg/kg, paracetamol, paracetamol + idebenone 25 mg/kg, paracetamol + idebenone 50 mg/kg, and paracetamol + idebenone 100 mg/kg. Serum ALT and AST levels were measured, and hepatic SOD, GSH, and MDA levels were evaluated. The mRNA expression levels of NF-κB, TNF-α, IL-6, Nrf2, and HO-1 were determined by qRT-PCR. Histopathological examination and immunohistochemical analyses of TNF-α, STAT3, Nrf2, and PI3K were also performed. Paracetamol administration significantly increased serum ALT and AST levels and hepatic MDA levels, while decreasing SOD and GSH levels. It also increased NF-κB, TNF-α, and IL-6 mRNA expression and decreased Nrf2 and HO-1 expression. Idebenone treatment significantly improved these biochemical and molecular alterations, with a more pronounced effect at higher doses. Histopathological examination showed severe hepatocellular degeneration, necrosis, sinusoidal dilatation, and inflammatory cell infiltration in the paracetamol group, whereas these changes were progressively reduced by idebenone treatment. Immunohistochemical analysis showed increased TNF-α and STAT3 immunoreactivity and decreased Nrf2 and PI3K expression after paracetamol administration. Idebenone attenuated these changes, showing a dose-related trend toward improvement, with the most pronounced effect observed at 100 mg/kg. Idebenone showed a marked protective effect against paracetamol-induced acute liver injury. Its hepatoprotective effect may be related to the reduction in oxidative stress and inflammation together with possible contribution of Nrf2/HO-1-associated antioxidant defence and regulation of PI3K and STAT3-related responses.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-19
DOI
https://doi.org/10.3390/antiox15111503
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hepatoprotective Effects of Idebenone Against Paracetamol-Induced Liver Injury: Association with Nrf2/HO-1 and NF-κB Signaling Pathways

Muhammet Ali Gürbüz, Elif Çadırcı, Hamza Halıcı, Zekai Halıcı et al.
Antioxidants
Drug-Induced Hepatotoxicity and Protection
article

Hepatoprotective Effects of Idebenone Against Paracetamol-Induced Liver Injury: Association with Nrf2/HO-1 and NF-κB Signaling Pathways

Muhammet Ali Gürbüz, Elif Çadırcı, Hamza Halıcı, Zekai Halıcı, Saliha Sena Karcioğlu, Metin Kılıçlıoğlu, Serkan Yıldırım, Nagihan Demirtaş, Hakan Dursun
article en

Abstract

Paracetamol overdose is a common cause of acute liver injury and is closely associated with oxidative stress and inflammation. Idebenone is a coenzyme Q10 analogue with antioxidant and mitochondrial protective properties. This study aimed to investigate the protective effects of idebenone against paracetamol-induced liver injury in rats. Forty-eight male Wistar rats were divided into six groups: healthy, healthy + idebenone 100 mg/kg, paracetamol, paracetamol + idebenone 25 mg/kg, paracetamol + idebenone 50 mg/kg, and paracetamol + idebenone 100 mg/kg. Serum ALT and AST levels were measured, and hepatic SOD, GSH, and MDA levels were evaluated. The mRNA expression levels of NF-κB, TNF-α, IL-6, Nrf2, and HO-1 were determined by qRT-PCR. Histopathological examination and immunohistochemical analyses of TNF-α, STAT3, Nrf2, and PI3K were also performed. Paracetamol administration significantly increased serum ALT and AST levels and hepatic MDA levels, while decreasing SOD and GSH levels. It also increased NF-κB, TNF-α, and IL-6 mRNA expression and decreased Nrf2 and HO-1 expression. Idebenone treatment significantly improved these biochemical and molecular alterations, with a more pronounced effect at higher doses. Histopathological examination showed severe hepatocellular degeneration, necrosis, sinusoidal dilatation, and inflammatory cell infiltration in the paracetamol group, whereas these changes were progressively reduced by idebenone treatment. Immunohistochemical analysis showed increased TNF-α and STAT3 immunoreactivity and decreased Nrf2 and PI3K expression after paracetamol administration. Idebenone attenuated these changes, showing a dose-related trend toward improvement, with the most pronounced effect observed at 100 mg/kg. Idebenone showed a marked protective effect against paracetamol-induced acute liver injury. Its hepatoprotective effect may be related to the reduction in oxidative stress and inflammation together with possible contribution of Nrf2/HO-1-associated antioxidant defence and regulation of PI3K and STAT3-related responses.

AntioxidantsVol. 15(11)
Kyrgyz-Türkish Manas Üniversity (KG), Atatürk University (TR)
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon